High basal Wnt signaling is further induced by PI3K/mTor inhibition but sensitive to cSRC inhibition in mammary carcinoma cell lines with HER2/3 overexpression
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High basal Wnt signaling is further induced by PI3K/mTor inhibition but sensitive to cSRC inhibition in mammary carcinoma cell lines with HER2/3 overexpression
Authors
Keywords
Wnt signaling, PI3K/AKT/mTOR, cSRC, PTEN, HER2/3, Mammary cancer, Canine
Journal
BMC CANCER
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-07-24
DOI
10.1186/s12885-015-1544-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance
- (2015) H. M. Stern et al. CLINICAL CANCER RESEARCH
- Regulation of ERBB3/HER3 signaling in cancer
- (2015) Kalpana Mujoo et al. Oncotarget
- Molecular Homology and Difference between Spontaneous Canine Mammary Cancer and Human Breast Cancer
- (2014) D. Liu et al. CANCER RESEARCH
- Novel Peptidomimetics for Inhibition of HER2:HER3 Heterodimerization in HER2-Positive Breast Cancer
- (2014) Shanthi Kanthala et al. Chemical Biology & Drug Design
- Ligand-Independent Canonical Wnt Activity in Canine Mammary Tumor Cell Lines Associated with Aberrant LEF1 Expression
- (2014) Ana Gracanin et al. PLoS One
- T47D breast cancer cells switch from ER/HER to HER/c-Src signaling upon acquiring resistance to the antiestrogen fulvestrant
- (2013) Tove Kirkegaard et al. CANCER LETTERS
- Everolimus: a new hope for patients with breast cancer
- (2013) Mehmet A.N. Sendur et al. CURRENT MEDICAL RESEARCH AND OPINION
- The quest to overcome resistance to EGFR-targeted therapies in cancer
- (2013) Curtis R Chong et al. NATURE MEDICINE
- A case study of personalized therapy for osteosarcoma
- (2013) Lara E. Davis et al. PEDIATRIC BLOOD & CANCER
- Mapping C-Terminal Transactivation Domains of the Nuclear HER Family Receptor Tyrosine Kinase HER3
- (2013) Toni M. Brand et al. PLoS One
- PI3K regulates MEK/ERK signaling in breast cancer via the Rac-GEF, P-Rex1
- (2013) H. Ebi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Progesterone Decreases Levels of the Adhesion Protein E-Cadherin and Promotes Invasiveness of Steroid Receptor Positive Breast Cancers
- (2013) Anastasia Kariagina et al. Hormones & Cancer
- Inhibition of PI3K/mTOR Leads to Adaptive Resistance in Matrix-Attached Cancer Cells
- (2012) Taru Muranen et al. CANCER CELL
- cMET and Phospho-cMET Protein Levels in Breast Cancers and Survival Outcomes
- (2012) K. P. Raghav et al. CLINICAL CANCER RESEARCH
- Progesterone and estrogen receptors segregate into different cell subpopulations in the normal human breast
- (2012) H.N. Hilton et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Activation Status of Wnt/ß-Catenin Signaling in Normal and Neoplastic Breast Tissues: Relationship to HER2/neu Expression in Human and Mouse
- (2012) Sara Khalil et al. PLoS One
- Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor–positive early breast cancer patients
- (2011) Johanna G. H. van Nes et al. BREAST CANCER RESEARCH AND TREATMENT
- Dependence on the MUC1-C Oncoprotein in Non-Small Cell Lung Cancer Cells
- (2011) D. Raina et al. MOLECULAR CANCER THERAPEUTICS
- Focal adhesion kinase inhibitors are potent anti-angiogenic agents
- (2011) Miguel A. Cabrita et al. Molecular Oncology
- Wnt/β-Catenin Pathway Activation Is Enriched in Basal-Like Breast Cancers and Predicts Poor Outcome
- (2010) Andrey I. Khramtsov et al. AMERICAN JOURNAL OF PATHOLOGY
- The PI3 kinase/mTOR blocker NVP-BEZ235 overrides resistance against irreversible ErbB inhibitors in breast cancer cells
- (2010) Caroline Brünner-Kubath et al. BREAST CANCER RESEARCH AND TREATMENT
- Inhibition profiles of phosphatidylinositol 3-kinase inhibitors against PI3K superfamily and human cancer cell line panel JFCR39
- (2010) Dexin Kong et al. EUROPEAN JOURNAL OF CANCER
- Interaction between human-breast cancer metastasis and bone microenvironment through activated hepatocyte growth factor/Met and β-catenin/Wnt pathways
- (2010) Sara Previdi et al. EUROPEAN JOURNAL OF CANCER
- When pathways collide: collaboration and connivance among signalling proteins in development
- (2010) Helen McNeill et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Expression of HER-2 and nuclear localization of HER-3 protein in canine mammary tumors: Histopathological and immunohistochemical study
- (2010) J.H. Kim et al. VETERINARY JOURNAL
- Comparative expression pathway analysis of human and canine mammary tumors
- (2009) Paolo Uva et al. BMC GENOMICS
- Loss of Phosphatase and Tensin Homologue Deleted on Chromosome 10 Engages ErbB3 and Insulin-Like Growth Factor-I Receptor Signaling to Promote Antiestrogen Resistance in Breast Cancer
- (2009) T. W. Miller et al. CANCER RESEARCH
- Phosphatidylinositol 3-Kinase Signaling Does Not Activate the Wnt Cascade
- (2009) Ser Sue Ng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dishevelled-2 docks and activates Src in a Wnt-dependent manner
- (2009) Noriko Yokoyama et al. JOURNAL OF CELL SCIENCE
- Regulation of Mammary Stem/Progenitor Cells by PTEN/Akt/β-Catenin Signaling
- (2009) Hasan Korkaya et al. PLOS BIOLOGY
- NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations
- (2008) V. Serra et al. CANCER RESEARCH
- Increased survival in dogs with malignant mammary tumours overexpressing HER-2 protein and detection of a silent single nucleotide polymorphism in the canine HER-2 gene
- (2007) Wei-Li Hsu et al. VETERINARY JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now